Abstract
Zika virus (ZIKV) is an emerging, mosquito-borne pathogen associated with a widespread 2015–2016 epidemic in the Western Hemisphere and a proven cause of microcephaly and other fetal brain defects in infants born to infected mothers. ZIKV infections have been also linked to other neurological illnesses in infected adults and children, including Guillain-Barré syndrome (GBS), acute flaccid paralysis (AFP) and meningoencephalitis, but the viral pathophysiology behind those conditions remains poorly understood. Here we investigated ZIKV infectivity in neuroblastoma SH-SY5Y cells, both undifferentiated and following differentiation with retinoic acid. We found that multiple ZIKV strains, representing both the prototype African and contemporary Asian epidemic lineages, were able to replicate in SH-SY5Y cells. Differentiation with resultant expression of mature neuron markers increased infectivity in these cells, and the extent of infectivity correlated with degree of differentiation. New viral particles in infected cells were visualized by electron microscopy and found to be primarily situated inside vesicles; overt damage to the Golgi apparatus was also observed. Enhanced ZIKV infectivity in a neural cell line following differentiation may contribute to viral neuropathogenesis in the developing or mature central nervous system.
Similar content being viewed by others
Introduction
Several arthropod-borne flaviviruses are neuropathogenic to humans1, including West Nile virus (WNV), Japanese encephalitis virus (JEV), tick-borne encephalitis virus, Powassan virus, and dengue virus2,3,4. Zika virus (ZIKV), transmitted by infected Aedes mosquito, is another viral pathogen in the Flaviviridae family and was originally discovered in Uganda in 1947. The acute illness caused by ZIKV is typically a self-limited febrile illness characterized by rash, conjunctivitis, and arthralgia. Prior to 2007, there were only 14 reported cases of ZIKV infection in humans5,6,7,8,9. A large ZIKV outbreak occurred in Yap Island in the western Pacific Ocean in 2007, during which 73% of the residents on the island were infected10,11 Since the Yap outbreak, the rapid and widespread emergence of ZIKV throughout the Western Hemisphere from 2014–2016 has uncovered more severe potential neurological manifestations associated with infection, including cases of Guillain-Barré Syndrome (GBS), meningoencephalitis, and acute flaccid paralysis12,13,14, as well as neurodevelopmental defects such as microcephaly in the infants of infected mothers15,16,17.
A number of in vitro and in vivo models of ZIKV infection have been developed in the last two years. The susceptibility of human neuronal progenitor cells (NPCs) to ZIKV infection was demonstrated in in vitro studies of induced pluripotent stem cells18 and with organoids and cortical neurospheres, which recapitulated the cell death, decrease in proliferation, and reduction of organoid volume that was seen in fetal tissues from microcephaly cases19,20. These studies demonstrated preferential ZIKV infection of progenitor stem cells, with only a minor percentage of mature neurons affected. Much less is known regarding ZIKV infection of mature, fully differentiated neurons.
Here we sought to establish an in vitro model for studying ZIKV infection in undifferentiated and differentiated neural cells of the brain. As a potential model for human adult mature neurons, we used ZIKV to infect the neuroblastoma cell line SH-SY5Y with and without pretreatment with retinoic acid (RA). RA plays different roles in the nervous system, including neural differentiation, axon outgrowth and neuronal patterning. The exact mechanisms of action for RA are still not completely understood, but its effect is associated with the activation of nuclear receptors and induction of different signaling pathways, such as the retinoic receptor and peroxisome proliferator activated-receptor. RA has been shown to promote neuronal differentiation in vitro by controlling cell cycle progression21,22,23.
The SH-SY5Y neuroblastoma cell line was originally derived from the cell line SK-N-SH (obtained from a metastatic bone marrow biopsy) as a neuroblast-like subclone after three passages. The subclone was characterized as a N-type neuronal cell line24. SH-SY5Y cells have been previously used for the study of several different viruses in vitro, including flaviviruses25,26,27,28. Although both undifferentiated and differentiated SH-SY5Y cells were found to be permissive for ZIKV infection29,30, the impact of differentiation on ZIKV infectivity and titers has yet to be fully described.
Results
We infected undifferentiated SH-SY5Y cells with the prototype 1947 Uganda strain (MR766) (ZIKV-UG), representing the African lineage, and the contemporary ZIKV strain PRVABC59 (ZIKV-PR), representing the currently circulating Asian lineage (Fig. 1A). At a multiplicity of infection (MOI) of 1, very few cells were positive for ZIKV envelope protein by immunofluorescent staining at 48 hours post-infection (Fig. 1B, top row). Increasing the MOI to 10 did not increase the proportion of infected cells by staining (Supplementary Fig. 1). In contrast, ZIKV infection of control Vero cells, highly permissive to ZIKV infection due to lack of interferon expression, was robust for both the ZIKV-UG and ZIKV-PR strains (Supplementary Fig. 1), and extent of infection was roughly proportional to the input virus concentration (Fig. 1B, bottom row; Supplementary Fig. 1). Interestingly, we observed that many of the infected SH-SY5Y cells showed extensions characteristic of differentiated cells, raising the question of whether differentiated SH-SY5Y cells are more susceptible to ZIKV infection.
To assess this possibility, we evaluated 2 independent established protocols for inducing differentiation of SH-SY5Y cells, incubation in 2% serum or treatment with all-trans-retinoic acid (RA). A treatment dose of 10 µM RA was selected as several studies had previously demonstrated robust differentiation at that concentration31,32,33. Regular SH-SY5Y growing media contained 10% fetal bovine serum. Although both protocols were successful in inducing differentiation, the more effective protocol was the addition of 10 µM RA for 2 days in 10% FBS media (Supplementary Fig. 2), which resulted in extensive production of neurites and formation of a stable monolayer (Supplementary Fig. 3A). To confirm that cells were differentiated, we monitored a number of previously characterized neuronal markers by RNA-Seq transcriptional profiling and immunofluorescent staining (Table 1). Following treatment with RA, there was an increase in the expression of multiple established markers of neuronal differentiation (Table 1 and Supplementary Fig. 3B), including MAP2 (microtubule-associated protein-2), synaptophysin (present at functional synapses), SatB (a transcriptional factor expressed in cortical neurons), GFAP (a marker of astrocytes), and TH (tyrosine hydroxyolase, a dopaminergic marker)34,35, as well as corresponding expected decreases in the abundance of vimentin and ID2 genes (Table 1)36.
Next, we infected differentiated SH-SY5Y cells (after 2 days of RA treatment) with the ZIKV-UG and ZIKV-PR strains and looked for the expression of viral antigen by immunofluorescent staining at 48 hr post-infection. For both strains, a higher proportion of ZIKV-positive cells (up to 70% higher for ZIKV-UG) was observed by immunofluorescence in differentiated cells versus undifferentiated cells (Fig. 1B; Supplementary Fig. 2). These results indicated that pretreatment of SH-SY5Y cells with RA and resultant differentiation rendered these cells more permissive to ZIKV infection. The use of low-serum media (2% FBS) for inducing differentiation also produced an increase in proportion of infected cells to ~60% in ZIKV-UG infected cells (Supplementary Fig. 2).
To determine whether mature differentiated cells were being preferentially infected by ZIKV in RA-treated SH-SY5Y cells, we co-stained these cells with immunofluorescent antibodies targeting the flaviviral envelope protein (anti-Env) and the neural differentiation marker TH (Supplementary Fig. 4). Most, but not all, of the infected cells positive for ZIKV using the anti-Env antibody were also positive with TH staining (Supplementary Fig. 4). This showed that although ZIKV-UG was able to infect both differentiated and undifferentiated cells, the proportion of infected cells was higher in those differentiated or undergoing differentiation. We then tested whether extended exposure to RA to induce more differentiation resulted in further increases in ZIKV-UG infection. SH-SY5Y cells were treated with RA for up to 8 days prior to viral infection (Fig. 2A) and infectious viral titers as a function of days of differentiation determined by plaque assay (Fig. 2B). RA treatment of 2 to 5 days in duration produced similar increases in infection, whereas extended treatment of 6 to 8 days resulted in a further 2-log increase in viral titers.
To investigate the hypothesis that decreases in the relative expression of interferon-associated genes may explain increased susceptibility of RA-differentiated versus undifferentiated SH-SY5Y cells to ZIKV infection, we analyzed the transcriptome profiling data for levels of expression of interferon-stimulated genes (ISGs). We did not observe down-regulation of ISGs in differentiated cells; rather, genes associated with type I interferon signaling, such as IRF9 and STAT2, were up-regulated in RA-differentiated cells, and the only significantly down-regulated gene identified, DSCT1, was a negative regulator of type I interferon signaling37. This suggested that the enhanced ZIKV infection in RA-differentiated cells was not due to basal decreases in the expression of ISGs.
The Axl protein has been postulated as a putative cell entry receptor for ZIKV. To determine whether the observed enhanced infection in differentiated cells following 2 days of RA treatment was due to increased expression of AxI, we stained differentiated and undifferentiated SH-SY5Y cells (both uninfected and after 48 hours infection by ZIKV-UG or ZIKV-PR) with an Axl-specific monoclonal antibody, which detects endogenous levels of total Axl. Under all tested conditions, the Axl immunofluorescent signal was at the noise level (Supplementary Fig. 5), similar to that using only the secondary antibody as a negative control. Consistent with this observation, analysis of Axl RNA by RNA-Seq transcriptome analysis showed basal levels of expression, which were not increased after RA treatment; the FPKM (fragments per kilobase of transcript per million mapped reads) value was 0.0072 in undifferentiated cells and 0.0063 in RA treated cells, indicating a non-significant log2 fold change of −0.19 (using a log2 fold change of ≥1.5 as a cutoff for significance)38. This indicated that Axl was not expressed at a detectable level in either differentiated or undifferentiated SH-SY5Y cells.
Next, we infected differentiated SH-SY5Y cells after 48 hours of RA treatment with mock supernatant (Fig. 3A) or ZIKV-UG (Fig. 3B–D), and fixed and processed the samples at 48 hr post-infection for visualization by transmission electron microscopy. In ZIKV-UG infected cells, we observed clusters of high-density spherical viral particles ~50 nm in diameter inside cytoplasmic vesicles and the Golgi apparatus (Fig. 3B–D). Overt distortion and membrane disruption of the Golgi complex were observed in multiple areas (Fig. 3B,C). Differentiated SH-SY5Y cells were also infectable by 3 additional ZIKV strains in the Asian lineage: the Malaysian strain P6740 (ZIKV-MAL), the Cambodian strain FSS13025 (ZIKV-CAM) and the Brazil strain SPH2015 (ZIKV-BR) (Fig. 4).
Discussion
In this study, we report productive infection of neuroblastoma SH-SY5Y cells by multiple ZIKV strains from the African and Asian lineages. Although the African ZIKV-UG strain has been passed extensively in mouse brain39, all of the contemporary, low-passage Asian strains were able to infect these cells. We also present evidence that differentiated SH-SY5Y cells resembling mature neurons are more efficiently infected by ZIKV than undifferentiated cells. Increased susceptibility of neural SH-SY5Y cells to ZIKV infection with degree of differentiation suggests a role for enhanced viral infection in ZIKV-associated neuroinvasive diseases in both adults and children, including acute flaccid paralysis (AFP) and meningoencephalitis. Enhanced viral infection in the setting of actively differentiating neurons in the developing brain may be a contributing factor in ZIKV-associated fetal neurodevelopmental disorders such as microcephaly
Successful differentiation of SH-SY5Y cells after two days of RA treatment was documented by the presence of neural extensions and expression of cell markers characteristic of mature neurons. Cells differentiated using two independent methods were more susceptible to ZIKV infection than undifferentiated cells, as evidenced by a higher proportion of infected cells by immunofluorescence and infectious viral titers in the supernatant. These findings contrast with those of a previous study showing that partially differentiated SH-SY5Y neuroblastoma cells were not more susceptible to infection than undifferentiated cells, and that two terminally differentiated olfactory bulb neuroblastoma cell lines were reported as resistant to ZIKV infection29. The discrepancy in these observations is likely due to differences in experimental design. In the aforementioned report, SH-SY5Y cells were cultured up to 7 days and then infected with ZIKV, whereas in our experiments cells were infected soon after seeding or after 2 days of RA treatment. Specifically, we observed that culturing of uninfected SH-SY5Y cells for >3 days resulted in the production of neurite extensions, even in standard 10% FBS media. Another difference that may account for the discrepant results between the prior study and ours may be the approach used for differentiation: here we used 10 µM RA for differentiation, as done previously32, and confirmed differentiation by assaying for the presence of mature neuronal markers, whereas only 1 µM RA was used in the previous study29.
Some potential explanations for the observed enhancement of ZIKV infection following differentiation are down-regulation of antiviral responses or different receptor usage in differentiated relative to undifferentiated cells. However, we found by transcriptome profiling that the overall basal expression of ISGs in RA-differentiated SH-SY5Y cells was increased, and not decreased, relative to undifferentiated cells. In addition, we did not detect evidence of increased expression of Axl, proposed as a candidate receptor for ZIKV40. Multiple lines of evidence from other published reports corroborate our finding of low or absent baseline Axl expression in SH-SY5Y cells, indicating that Axl is not necessary for ZIKV infection in this neural cell line. First, Axl expression has not been detected in other neuroblastoma cell lines such as JMR32 and SK-N-SH41,42. Second, the use of alternative receptors to Axl for ZIKV entry in neuronal cells has been demonstrated, as infection of the eye and optic nerve by ZIKV in adult mice was found to be Axl-independent43. Third, Axl signaling is not required for productive ZIKV replication in human astrocytes44, nor for infection of human and murine brain organoids or mice lacking Axl protein20,43. Further investigation will be needed to determine the underlying mechanism(s) for the increased susceptibility of differentiated SH-SY5Y neuroblastoma cells to ZIKV infection.
Materials and Methods
Cell lines and reagents
Human neuroblastoma cells SH-SY5Y (ATCC CRL-2266) and African green monkey kidney VERO E6 cells (ATCC CRL1586) were obtained from the American Type Culture Collection (ATCC, Manassas, VA). SH-SY5Y were cultured in 1:1 Eagle’s Minimum Essential Media (EMEM) and Ham’s F12 supplemented with 10% v/v fetal bovine serum (FBS), 1% penicillin-streptomycin, and 2 mM glutamine (Sigma-Aldrich, Carlsbad, CA). Cells were maintained in a logarithmic phase of growth in 25 mL or 75 mL plastic culture flasks (BD Falcon). SH-SY5Y cells were differentiated by treatment with 10 µM retinoic acid (RA) (Life Technologies). All cells were maintained at 37 °C in a humidified incubator with a 5% CO2 atmosphere.
ZIKV strain PRVABC59 (ZIKV-PR) was obtained from the Centers for Disease Control and Prevention (CDC) (GenBank accession number KU501215), and passed twice in Vero cells. This strain was originally isolated in 2015 from the serum of a patient who traveled to Puerto Rico, and had been passaged three times in Vero cells. The prototype African ZIKV strain MR766 ZIKV-UG) was provided by the California Department of Public Health (Richmond, CA); this strain was isolated in Uganda in 1947, and has since been passed 147 times in mice brain and 3 times in Vero cells. The Cambodian strain FSS13025 (ZIKV-CAM) was isolated in 2010 and provided by Joseph DeRisi at University of California, San Francisco (UCSF) (San Francisco, CA). The Brazil strain SPH2015 (ZIKV-BR) was isolated in 2015 (GenBank accession number KU321639)45, and was provided by Marion Lanteri at the Blood Systems Research Institute (San Francisco, CA). The Malaysian strain P6740 (ZIKV-MAL) was provided by Raul Andino at UCSF. The last 3 aforementioned strains were propagated in Vero cells infected at an MOI of 0.01 and kept at low passage numbers. ZIKV supernatants used for infection experiments were collected at 96 or 120 hours post-infection (hpi) and clarified by centrifugation at 350 × g for 30 min. The ZIKV-UG, ZIKV-PR and ZIKV-BR cultures were sequenced on a MiSeq instrument at >10X redundancy and no differences between the assembled consensus sequence and GenBank reference sequence were found. Flavivirus group envelope mouse monoclonal antibody (mAb) (anti-Env), which cross-reacts with ZIKV and other flaviviruses such as dengue virus, was obtained from EMD Millipore (catalog number MAB10216, clone D1-4G2-4-15). For Axl detection, rabbit mAb C89E7 (Cell Signaling Technology, Danvers, MA) was used.
Virus infection
SH-SY5Y cells were plated in 24-well plates at a concentration of 2 × 105 per well and infected with different ZIKV strains at a multiplicity of infection (MOI) of 0.1. 1 or 10, for one hour, followed by washing twice, and then kept in MEM and 1% FBS media.
Immunofluorescence
Differentiated or undifferentiated cells were infected with ZIKV, fixed with 4% paraformaldehyde for 10 min, washed twice with 0.2% bovine serum albumin and phosphate-buffered saline (BSA/PBS), and incubated with primary antibody for 30–60 min at room temperature. Next, cells were washed twice with 0.2% BSA/PBS, incubated with secondary antibody for 30 min, and finally washed twice again with 0.2% BSA/PBS. Cells were permeabilized with 0.1% Triton X-100 (Thermo-Fisher Scientific) for analysis of internal epitopes, or fixed directly with cold methanol for 10 min. Stained cells were analyzed using a Nikon C1si or Ti confocal microscopes.
Measurement of infectious ZIKV titers by plaque assay
Vero cells were plated in 6-well plates at a concentration of 3 × 105 per well. After 2 days of growth, 500 µL serial dilutions of ZIKV-infected supernatant from 10−2 to 10−7 were added to duplicate wells of 6-well plates, followed by incubation at 37 °C for 1 hr for adsorption. After adsorption, the inoculum was removed from each well and overlaid with 2X Eagle’s Minimum Essential Medium with 1% FBS, 1% penicillin-streptomycin and 2 mM glutamine, and 1% of carboxymethyl cellulose in PBS in a 1:1 ratio. Plates were maintained at 37 °C, 5% CO2 for five days, followed by fixation and staining of the cells with 2 mL of crystal violet solution (0.25% crystal violet, 10% methanol, 1.75% formaldehyde, 0.5% CaCl and 35 mM of Tris Base) per well. After 15–20 min incubation and rinsing with tap water, plaques were counted and calculated in plaque forming units per mL (PFU/mL). Statistical analysis was performed with GraphPad Prism software (version 7).
RNA-Seq transcriptome profiling
Total RNA from cell culture lysates (1 million cells/sample) was extracted using the Direct-zol RNA MiniPrep Kit (Zymo Research). The Ovation Human Blood RNA-Seq Kit (NuGEN Technologies Inc., San Carlos, CA) was used to generate strand-specific RNA-seq libraries. Libraries were sequenced as 100 base pair (bp) paired-end runs on a HiSeq. 2500 instrument (Illumina, San Diego, CA). Paired-end reads were mapped to the human genome (hg19) using STAR v3.12.246, gene and transcript counts were calculated by HTSeq v0.6047. Differential expression of genes was performed using EdgeR v3.12.248 implemented in the R programming language. Genes with fold change >±2, p-value < 0.05, and adjusted p-value (or false discovery rate, FDR) < 0.1% are considered to be differentially expressed. Pathway and network analyses of the transcriptome data were performed using Ingenuity Pathway Analysis software (Qiagen, Valencia, CA). In order to identify the DEGs related to interferon pathways, we retrieved the complete list of interferon pathways genes using the PANTHER database49.
RNA extraction and quantitative reverse transcription polymerase chain reaction (qRT-PCR)
Total RNA from cell culture lysates and corresponding supernatants was extracted using the Direct-zol RNA MiniPrep Kit (Zymo Research, Tustin, CA). ZIKV RNA loads were determined by qRT-PCR testing using primers targeting the envelope gene (ZIKV-1086-ZIKV-1162)10.
Electron microscopy
Cells were collected at 48 hours post infection and fixed in 2% glutaraldehyde, 1% paraformaldehyde in 0.1 M sodium cacodylate buffer pH 7.4, followed by post-fixation in 2% osmium tetroxide in the same buffer, staining with 2% aqueous uranyl acetate, dehydration in acetone, and embedding in LX-112 resin (Ladd Research Industries, Burlington, VT). Samples were sectioned on a Reichert Ultracut S ultramicrotome and counterstained with 0.8% lead citrate. Grids were examined on a JEOL JEM-1230 transmission electron microscope (JEOL USA, Inc., Peabody, MA) and photographed with the Gatan Ultrascan 1000 digital camera (Gatan Inc., Warrendale, PA).
Accession numbers
RNA-seq data from transcriptome profiling of SH-SY5Y cells have been submitted to the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) repository (BioProject accession number PRJNA234047).
References
Li, H., Saucedo-Cuevas, L., Shresta, S. & Gleeson, J. G. The Neurobiology of Zika Virus. Neuron 92, 949–958, https://doi.org/10.1016/j.neuron.2016.11.031 (2016).
Ludlow, M. et al. Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol 131, 159–184, https://doi.org/10.1007/s00401-015-1511-3 (2016).
Winkelmann, E. R., Luo, H. & Wang, T. West Nile Virus Infection in the Central Nervous System. F1000Res 5, https://doi.org/10.12688/f1000research.7404.1 (2016).
Madi, D. et al. Dengue encephalitis-A rare manifestation of dengue fever. Asian Pac J Trop Biomed 4, S70–72, https://doi.org/10.12980/APJTB.4.2014C1006 (2014).
Fagbami, A. H. Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg (Lond) 83, 213–219 (1979).
Filipe, A. R., Martins, C. M. & Rocha, H. Laboratory infection with Zika virus after vaccination against yellow fever. Arch Gesamte Virusforsch 43, 315–319 (1973).
Moore, D. L. et al. Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann Trop Med Parasitol 69, 49–64 (1975).
Olson, J. G. & Ksiazek, T. G. Suhandiman & Triwibowo. Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg 75, 389–393 (1981).
Simpson, D. I. Zika Virus Infection in Man. Trans R Soc Trop Med Hyg 58, 335–338 (1964).
Duffy, M. R. et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360, 2536–2543, https://doi.org/10.1056/NEJMoa0805715 (2009).
Faye, O. et al. Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS Negl Trop Dis 8, e2636, https://doi.org/10.1371/journal.pntd.0002636 (2014).
Carteaux, G. et al. Zika Virus Associated with Meningoencephalitis. N Engl J Med 374, 1595–1596, https://doi.org/10.1056/NEJMc1602964 (2016).
Craig, A. T., Butler, M. T., Pastore, R., Paterson, B. J. & Durrheim, D. N. Acute flaccid paralysis incidence and Zika virus surveillance, Pacific Islands. Bull World Health Organ 95, 69–75, https://doi.org/10.2471/BLT.16.171892 (2017).
Parra, B. et al. Guillain-Barre Syndrome Associated with Zika Virus Infection in Colombia. N Engl J Med 375, 1513–1523, https://doi.org/10.1056/NEJMoa1605564 (2016).
Chibueze, E. C. et al. Zika virus infection in pregnancy: a systematic review of disease course and complications. Reprod Health 14, 28, https://doi.org/10.1186/s12978-017-0285-6 (2017).
Mlakar, J. et al. Zika Virus Associated with Microcephaly. N Engl J Med 374, 951–958, https://doi.org/10.1056/NEJMoa1600651 (2016).
Rasmussen, S. A., Jamieson, D. J. & Honein, M. A. & Petersen, L. R. Zika Virus and Birth Defects–Reviewing the Evidence for Causality. N Engl J Med 374, 1981–1987, https://doi.org/10.1056/NEJMsr1604338 (2016).
Tang, H. et al. Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth. Cell Stem Cell 18, 587–590, https://doi.org/10.1016/j.stem.2016.02.016 (2016).
Cugola, F. R. et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267–271, https://doi.org/10.1038/nature18296 (2016).
Garcez, P. P. et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 352, 816–818, https://doi.org/10.1126/science.aaf6116 (2016).
Janesick, A., Wu, S. C. & Blumberg, B. Retinoic acid signaling and neuronal differentiation. Cell Mol Life Sci 72, 1559–1576, https://doi.org/10.1007/s00018-014-1815-9 (2015).
Xu, J. et al. Retinoic acid promotes neural conversion of mouse embryonic stem cells in adherent monoculture. Mol Biol Rep 39, 789–795, https://doi.org/10.1007/s11033-011-0800-8 (2012).
Yu, S., Levi, L., Siegel, R. & Noy, N. Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta). J Biol Chem 287, 42195–42205, https://doi.org/10.1074/jbc.M112.410381 (2012).
Ross, R. A., Spengler, B. A. & Biedler, J. L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71, 741–747 (1983).
Du, X. et al. Enterovirus 71 induces apoptosis of SHSY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Mol Med Rep 12, 953–959, https://doi.org/10.3892/mmr.2015.3482 (2015).
Huhtamo, E. et al. Novel flaviviruses from mosquitoes: mosquito-specific evolutionary lineages within the phylogenetic group of mosquito-borne flaviviruses. Virology 464–465, 320–329, https://doi.org/10.1016/j.virol.2014.07.015 (2014).
Kalia, M., Khasa, R., Sharma, M., Nain, M. & Vrati, S. Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism. J Virol 87, 148–162, https://doi.org/10.1128/JVI.01399-12 (2013).
La Monica, N. & Racaniello, V. R. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J Virol 63, 2357–2360 (1989).
Hughes, B. W., Addanki, K. C., Sriskanda, A. N., McLean, E. & Bagasra, O. Infectivity of Immature Neurons to Zika Virus: A Link to Congenital Zika Syndrome. EBioMedicine 10, 65–70, https://doi.org/10.1016/j.ebiom.2016.06.026 (2016).
Luplertlop, N. et al. The impact of Zika virus infection on human neuroblastoma (SH-SY5Y) cell line. J Vector Borne Dis 54, 207–214 (2017).
Agholme, L., Lindstrom, T., Kagedal, K., Marcusson, J. & Hallbeck, M. An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimers Dis 20, 1069–1082, https://doi.org/10.3233/JAD-2010-091363 (2010).
Cheung, Y. T. et al. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30, 127–135, https://doi.org/10.1016/j.neuro.2008.11.001 (2009).
Dwane, S., Durack, E. & Kiely, P. A. Optimising parameters for the differentiation of SH-SY5Y cells to study cell adhesion and cell migration. BMC Res Notes 6, 366, https://doi.org/10.1186/1756-0500-6-366 (2013).
Gordon, J., Amini, S. & White, M. K. General overview of neuronal cell culture. Methods Mol Biol 1078, 1–8, https://doi.org/10.1007/978-1-62703-640-5_1 (2013).
Khwanraj, K., Phruksaniyom, C., Madlah, S. & Dharmasaroja, P. Differential Expression of Tyrosine Hydroxylase Protein and Apoptosis-Related Genes in Differentiated and Undifferentiated SH-SY5Y Neuroblastoma Cells Treated with MPP(.). Neurol Res Int 2015, 734703, https://doi.org/10.1155/2015/734703 (2015).
Lopez-Carballo, G., Moreno, L., Masia, S., Perez, P. & Barettino, D. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277, 25297–25304, https://doi.org/10.1074/jbc.M201869200 (2002).
Nair, S., Bist, P., Dikshit, N. & Krishnan, M. N. Global functional profiling of human ubiquitome identifies E3 ubiquitin ligase DCST1 as a novel negative regulator of Type-I interferon signaling. Sci Rep 6, 36179, https://doi.org/10.1038/srep36179 (2016).
Akond, Z., Alam, M. & Mollah, M. N. H. Biomarker Identification from RNA-Seq Data using a Robust Statistical Approach. Bioinformation 14, 153–163, https://doi.org/10.6026/97320630014153 (2018).
Morrison, T. E. & Diamond, M. S. Animal Models of Zika Virus Infection, Pathogenesis, and Immunity. J Virol 91, https://doi.org/10.1128/JVI.00009-17 (2017).
Nowakowski, T. J. et al. Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells. Cell Stem Cell 18, 591–596, https://doi.org/10.1016/j.stem.2016.03.012 (2016).
Debruyne, D. N. et al. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene 35, 3681–3691, https://doi.org/10.1038/onc.2015.434 (2016).
Vajkoczy, P. et al. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci USA 103, 5799–5804, https://doi.org/10.1073/pnas.0510923103 (2006).
Miner, J. J. et al. Zika Virus Infection in Mice Causes Panuveitis with Shedding of Virus in Tears. Cell Rep 16, 3208–3218, https://doi.org/10.1016/j.celrep.2016.08.079 (2016).
Retallack, H. et al. Zika virus cell tropism in the developing human brain and inhibition by azithromycin. Proc Natl Acad Sci USA 113, 14408–14413, https://doi.org/10.1073/pnas.1618029113 (2016).
Cunha, M. S. et al. First Complete Genome Sequence of Zika Virus (Flaviviridae, Flavivirus) from an Autochthonous Transmission in Brazil. Genome Announc 4, https://doi.org/10.1128/genomeA.00032-16 (2016).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21, https://doi.org/10.1093/bioinformatics/bts635 (2013).
Anders, S., Pyl, P. T. & Huber, W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169, https://doi.org/10.1093/bioinformatics/btu638 (2015).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140, https://doi.org/10.1093/bioinformatics/btp616 (2010).
Thomas, P. D. et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13, 2129–2141, https://doi.org/10.1101/gr.772403 (2003).
Acknowledgements
We would like to acknowledge Marion Lanteri (Blood Systems Research Institute), Lark Coffey (Blood Systems Research Institute), Raul Andino (UCSF), Shigeo Yagi (California Department of Public Health) and Joseph DeRisi (UCSF) for sharing reagents. Data for this study were acquired at the Nikon Imaging Center at UCSF. This study was also supported NIH grants R01-HL105704 and R21-AI129455, and award from Abbott Laboratories, Inc. to CYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
C.S.S. and C.Y.C. conceived and designed the experiments. C.S.S., T.L., G.Y., and J.S. performed the experiments. C.S.S., T.L., J.B., A.P., and C.Y.C. analyzed the data. C.S.S. and C.Y.C. contributed reagents/materials/analysis tools. C.S.S. and C.Y.C. wrote the paper. C.S.S. and C.Y.C. prepared the figures. All authors reviewed and edited the manuscript and agree to its contents.
Corresponding author
Ethics declarations
Competing Interests
C.Y.C. is the director of the UCSF-Abbott Viral Diagnostics and Discovery Center and receives research support from Abbott Laboratories. The other authors disclose no conflicts of interest.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sánchez-San Martín, C., Li, T., Bouquet, J. et al. Differentiation enhances Zika virus infection of neuronal brain cells. Sci Rep 8, 14543 (2018). https://doi.org/10.1038/s41598-018-32400-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-32400-7
- Springer Nature Limited
Keywords
This article is cited by
-
Metabolic reprogramming and lipid droplets are involved in Zika virus replication in neural cells
Journal of Neuroinflammation (2023)
-
Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication
Scientific Reports (2022)
-
Analysis of the long noncoding RNA profiles of RD and SH-SY5Y cells infected with coxsackievirus B5, using RNA sequencing
Archives of Virology (2022)
-
Axonal variants of Guillain–Barré syndrome: an update
Journal of Neurology (2021)